GSK licenses companies to make cheap copies of HIV prevention drug

  • 📰 Reuters
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

British drugmaker GSK has signed deals with three companies allowing them to make inexpensive generic versions of its long-acting HIV preventive medicine for use in lower-income countries, where the majority of new HIV cases occur

The generic copies will be supplied in 90 countries, subject to regulatory approvals there, the statement said.

Indian drugmaker Cipla will make the injections in India and has plans to manufacture in South Africa, which is trying to grow its drugs manufacturing industry to meet the continent's needs and reduce dependency on imports that was exposed by the COVID-19 pandemic. Pre-exposure prophylaxis is an effective way for an at-risk HIV-negative person to reduce the risk of infection. But until recently, PrEP was only available in pill form. GSK's product is the first non-pill option.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 2. in İD
 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.

Yup? Yep!

um, why is it a thing to send the generics to Africa and Asia and Latin America and elsewhere? seems messed up and makes me question the purity of generic drugs.

Indonesia Berita Terbaru, Indonesia Berita utama